Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06651580 · ClinicalTrials.gov registry record
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
A clinical trial of Chronic Pancreatitis and Recurrent Acute Pancreatitis, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 1,600
- Enrollment target
- 20
- Study locations
NCT06651580 is a study of Chronic Pancreatitis and Recurrent Acute Pancreatitis that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,600 participants, above the 651-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (146% higher). The trial reports 20 study locations across 13 states.
The verdict
NCT06651580, a study of Chronic Pancreatitis and Recurrent Acute Pancreatitis, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 1,600 participants
- Enrollment target
- 20
- Study locations
Study Summary
This clinical trial collects blood, saliva, urine, or stool samples to help identify possible genetic mutations that may increase a person's chance at developing pancreatic cancer. Finding genetic markers among pediatric patients with acute recurrent pancreatitis and chronic pancreatitis may help identify patients who are at risk of pancreatic cancer.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
Study Locations (20)
California
- Children's Hospital Los Angeles - Los Angeles
- Cedars Sinai Medical Center - Los Angeles
- UCSF Benioff Children's Hospital Oakland - Oakland
- Stanford Cancer Institute Palo Alto - Palo Alto
Texas
- University of Texas Southwestern/Children's Medical Center - Dallas
- M D Anderson Cancer Center - Houston
- Texas Children's Hospital - Houston
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
- Nationwide Children's Hospital - Columbus
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
- Children's Hospital of Pittsburgh of UPMC - Pittsburgh
Colorado
- University of Colorado - Denver
Georgia
- Emory University Hospital/Winship Cancer Institute - Atlanta
Indiana
- Riley Hospital for Children - Indianapolis
Iowa
- University of Iowa/Holden Comprehensive Cancer Center - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2027-02-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06651580
The ClinicalTrials.gov registry entry for NCT06651580 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 651-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (146% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Chronic Pancreatitis appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT06651580 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Texas, Ohio.
Frequently Asked Questions
What is clinical trial NCT06651580 about?
NCT06651580 is a clinical study titled "Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study". This clinical trial collects blood, saliva, urine, or stool samples to help identify possible genetic mutations that may increase a person's chance at developing pancreatic cancer. Finding genetic markers among pediatric patients with acute recurrent pancreatitis and chronic pancreatitis may help id...
What is the current status of trial NCT06651580?
This trial is currently recruiting. The enrollment target is 1,600 participants. The study started on 2021-04-01. Estimated completion is 2027-02-02.
What conditions does trial NCT06651580 study?
This clinical trial studies the following conditions: Chronic Pancreatitis, Recurrent Acute Pancreatitis, Exocrine Pancreas Carcinoma.
What interventions are being tested in trial NCT06651580?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT06651580?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06651580 being conducted?
This trial has 20 study locations across California, Colorado, Georgia, Indiana, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
RECRUITING
-
Analysis of Graft Function Following Autologous Islet Transplantation
RECRUITING
-
A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitis
RECRUITING · Early Phase 1
-
Scrambler Therapy in Chronic Pancreatitis
RECRUITING · NA
-
Pancreas Registry and High Risk Registry
RECRUITING
-
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.